Pioglitazone Use and Risk of Bladder Cancer: a Systematic Review and Meta-Analysis of Observational Studies

First published 07/11/2016

Last updated 30/03/2024

EU PAS number:

EUPAS16082

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

ER-9531 TAKEDA Pioglitazone meta-analysis study protocol v1.2 20161104_clean

English (330.93 KB - PDF)View document

Study results

Study results

Pioglitazone meta-analysis report abstract 2017-04-21

English (79.87 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents